Nalaganje...
Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT) anticoagulation is required. Heparin is still the most commonly used anticoagulant. However, heparins increase the risk of bleeding, especially in critically ill patients. Evidence has accumulated th...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672558/ https://ncbi.nlm.nih.gov/pubmed/23216871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11645 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|